The newly established Center for Molecular and Clinical Immunology at Chang Gung University is a research hub that integrates foundational immunology research with industrial applications. Focusing on clinical immunology, the center combines cutting-edge technologies and animal models to investigate the pathogenesis of human immune-related conditions, including infectious diseases, cancer, and autoimmune disorders.

Our current research topics include human anti-cytokine autoantibody diseases, innate immune deficiencies, infectious diseases, autoimmune disorders, and immune cell therapies. Core technologies driving our immunotherapeutic drug development include single B cell isolation for human antibody cloning and an mRNA-LNP platform.

Our team’s work has been published in leading journals such as Nature Medicine, Blood, Journal of Experimental Medicine, Science Immunology, Current Opinion in Immunology, and Journal of Clinical Immunology. We maintain active academic collaborations with internationally renowned institutions, including Rockefeller University (USA), the Imagine Institute (France), Lausanne University (Switzerland), and UC San Diego (USA). In addition, we actively partner with biomedical companies; two of our industry-academia collaboration projects have successfully transferred patent rights, with one project currently advancing through Phase I clinical trials.

Our laboratory facilities have been completely renovated, offering state-of-the-art research equipment alongside a comfortable environment with modern workstations and lounge areas. We provide a supportive ecosystem for both academic and translational research while actively fostering personal and career growth—offering diverse opportunities for future development, including industry-aligned training to support transitions into the biomedical sector.
lab
Go Back